Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer (Q74009028)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

R Silvestrini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

A Luisi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Zambetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Cipriani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P Valagussa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Bonadonna

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M G Daidone

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

405-411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

Changes in biological markers after primary chemotherapy for breast cancers

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Flexible regression models with cubic splines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820000801%2987%3A3%3C405%3A%3AAID-IJC15%3E3.0.CO%3B2-%23

10.1002/1097-0215(20000801)87:3<405::AID-IJC15>3.0.CO;2-#

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10897047%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference